Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The presence and severity of epilepsy coincide with reduced γ‐aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency

Epilepsia(2023)10.1111/epi.17592Source: DataRank Database

The presence and severity of epilepsy coincide with reduced γ‐aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency is a research paper published in Epilepsia (2023). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

omim nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.55)OA: bronzeTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Mariarita Bertoldi ORCID,Melissa L. DiBacco ORCID,Erland Arning ORCID,Melissa Tsuboyama ORCID,Paul MacMullin ORCID

Live enrichment

PubMed:36961285 PMC:PMC10471137 OpenAlex:https://openalex.org/W4360813901

National Institutes of Health

Grant: 1R01HD091142

NICHD NIH HHS

Grant: R01 HD091142

NICHD NIH HHS

Grant: P50 HD105351

FWCI

3.55

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.17592

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471137

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.17592

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17592

journalhttps://doi.org/10.1111/epi.17592

Fields of Study

Metabolism and Genetic DisordersForensic Toxicology and Drug AnalysisAlcoholism and Thiamine DeficiencyMedicineBiologyDevelopmental DisabilitiesEpilepsyChildgamma-Aminobutyric AcidAmino Acid Metabolism, Inborn ErrorsAminobutyratesSuccinate-Semialdehyde DehydrogenaseSodium OxybateHumansSeizuressuccinic semialdehyde dehydrogenase deficiency

MeSH Terms

Amino Acid Metabolism, Inborn ErrorsAminobutyratesChildDevelopmental DisabilitiesEpilepsygamma-Aminobutyric AcidHumansSeizuresSodium OxybateSuccinate-Semialdehyde Dehydrogenase

Keywords

EpilepsyVigabatrinInternal medicineStatus epilepticusMetaboliteGABAergicTranscranial magnetic stimulationEndocrinologyMedicinePsychologyNeuroscienceAnticonvulsantStimulationReceptorExcitationInhibitionSeizuresEpileptogenesisPathomechanism

Sustainable Development Goals

SDG 0: Reduced inequalities